Finding the Rare Pathogenic Variants in a Human Genome

JAMA. 2017 May 9;317(18):1904-1905. doi: 10.1001/jama.2017.0432.
No abstract available

MeSH terms

  • Cost-Benefit Analysis
  • Genetic Variation*
  • Genome, Human
  • Genotype
  • Healthy Volunteers
  • High-Throughput Nucleotide Sequencing*
  • Humans
  • Mass Screening
  • Mutation*
  • Penetrance
  • Polymorphism, Single Nucleotide
  • Precision Medicine